JD.com, Inc. (JDCMF)

Achilles Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	45,768	50,254	45,458	87,872	107,637	136,234
Market Cap Growth	38.88%	10.55%	-48.27%	-18.36%	-20.99%	164.83%
Enterprise Value	31,417	45,299	30,889	76,092	89,186	126,953
Last Close Price	16.00	17.03	13.44	27.65	34.00	42.99
PE Ratio	7.36	8.87	13.34	58.39	-	18.00
PS Ratio	0.28	0.32	0.30	0.58	0.72	1.19
PB Ratio	1.08	1.17	1.09	2.21	2.77	4.01
P/TBV Ratio	2.02	2.17	1.95	4.12	3.88	5.59
P/FCF Ratio	9.71	9.04	8.26	15.96	26.03	28.12
P/OCF Ratio	6.49	6.31	5.42	10.48	16.16	20.91
EV/Sales Ratio	0.19	0.28	0.20	0.50	0.60	1.11
EV/EBITDA Ratio	3.30	6.82	5.89	20.52	58.98	49.45
EV/EBIT Ratio	4.87	8.36	7.58	28.61	167.92	77.50
EV/FCF Ratio	6.67	8.15	5.61	13.82	21.57	26.21
Debt / Equity Ratio	0.28	0.29	0.23	0.24	0.14	0.14
Debt / EBITDA Ratio	1.35	1.46	1.36	1.74	1.76	1.33
Debt / FCF Ratio	2.56	2.21	1.75	1.71	1.30	1.00
Asset Turnover	1.88	1.75	1.77	1.92	2.07	2.19
Inventory Turnover	13.23	13.28	13.55	12.53	13.11	11.73
Quick Ratio	0.81	0.88	0.80	0.93	0.92	0.92
Current Ratio	1.26	1.29	1.16	1.32	1.35	1.35
Return on Equity (ROE)	16.28%	14.65%	8.15%	3.72%	-1.91%	30.62%
Return on Assets (ROA)	4.14%	3.73%	2.95%	2.10%	0.46%	1.96%
Return on Capital (ROIC)	7.03%	6.44%	5.13%	3.70%	0.79%	3.59%
Return on Capital Employed (ROCE)	10.80%	9.90%	8.00%	5.60%	1.20%	4.30%
Earnings Yield	13.59%	11.28%	7.50%	1.71%	-0.52%	5.56%
FCF Yield	10.30%	11.06%	12.11%	6.26%	3.84%	3.56%
Dividend Yield	3.13%	5.87%	5.65%	2.24%	-	-
Payout Ratio	12.27%	19.98%	27.89%	106.81%	-	-
Buyback Yield / Dilution	3.56%	2.98%	0.33%	-2.36%	0.05%	-4.78%
Total Shareholder Return	6.53%	8.85%	5.98%	-0.12%	0.05%	-4.78%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.